Lessons learned from BRCA1 and BRCA2

被引:131
|
作者
Zheng, L [1 ]
Li, S [1 ]
Boyer, TG [1 ]
Lee, WH [1 ]
机构
[1] Univ Texas, Hlth Sci Ctr, Inst Biotechnol, Dept Mol Med, San Antonio, TX 78245 USA
基金
美国国家卫生研究院;
关键词
BRCA1; BRCA2; breast cancer; tumor suppressor; transcription regulation; DNA damage repair;
D O I
10.1038/sj.onc.1203968
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
BRCA1 and BRCA2 are breast cancer susceptibility genes. Mutations within BRCA1 and BRCA1 are responsible for most familial breast cancer cases. Targeted deletion of Brca1 or Brca2 in mice has revealed an essential function for their encoded products, BRCA1 and BRCA2, in cell proliferation during embryogenesis. Mouse models established from conditional expression of mutant Brca1 alleles develop mammary gland tumors, providing compelling evidence that BRCA1 functions as a breast cancer suppressor. Human cancer cells and mouse cells deficient in BRCA1 or BRCA2 exhibit radiation hypersensitivity and chromosomal abnormalities, thus revealing a potential role for both BRCA1 and BRCA2 in the maintenance of genetic stability through participation in the cellular response to DIVA damage. Functional analyses of the BRCA1 and BRCA2 gene products have established their dual participation in transcription regulation and DNA damage repair. Potential insight into the molecular basis for these functions of BRCA1 and BRCA2 has been provided by studies that implicate these two tumor suppressors in both the maintenance of genetic stability and the regulation of cell growth and differentiation.
引用
收藏
页码:6159 / 6175
页数:17
相关论文
共 50 条
  • [21] Insights into the functions of BRCA1 and BRCA2
    Welcsh, PL
    Owens, KN
    King, MC
    TRENDS IN GENETICS, 2000, 16 (02) : 69 - 74
  • [22] BRCA1 and BRCA2: 1994 and beyond
    Steven A. Narod
    William D. Foulkes
    Nature Reviews Cancer, 2004, 4 : 665 - 676
  • [23] BRCA1 and BRCA2 in breast cancer
    Xiaohong Yang
    Marc E. Lippman
    Breast Cancer Research and Treatment, 1999, 54 : 1 - 10
  • [24] Are Endometrial Cancers Arising in BRCA1/BRCA2 Germline Mutations Carriers True BRCA1/BRCA2 Cancers?
    Paula, Arnaud Da Cruz
    Smith, Evan
    Cadoo, Karen
    Abu-Rustum, Nadeem
    Pei, Xin
    Riaz, Nadeem
    Robson, Mark
    Reis-Filho, Jorge
    Mandelker, Diana
    Weigelt, Britta
    MODERN PATHOLOGY, 2019, 32
  • [25] Are Endometrial Cancers Arising in BRCA1/BRCA2 Germline Mutations Carriers True BRCA1/BRCA2 Cancers?
    Paula, Arnaud Da Cruz
    Smith, Evan
    Cadoo, Karen
    Abu-Rustum, Nadeem
    Pei, Xin
    Riaz, Nadeem
    Robson, Mark
    Reis-Filho, Jorge
    Mandelker, Diana
    Weigelt, Britta
    LABORATORY INVESTIGATION, 2019, 99
  • [26] Screening for Genetic Mutations in BRCA1 and BRCA2
    Narod, Steven
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2015, 22 (12): : 1365 - 1365
  • [27] Functional domains of the BRCA1 and BRCA2 proteins
    Baer, R
    Lee, WH
    JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA, 1998, 3 (04) : 403 - 412
  • [28] Inactivation of BRCA1 and BRCA2 in ovarian cancer
    Hilton, JL
    Geisler, JP
    Rathe, JA
    Hattermann-Zogg, MA
    DeYoung, B
    Buller, RE
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2002, 94 (18): : 1396 - 1406
  • [29] Oophorectomy in women with BRCA1 or BRCA2 mutations
    Burki, Talha Khan
    LANCET ONCOLOGY, 2014, 15 (04): : E156 - E156
  • [30] Targeting BRCA1 and BRCA2 with NEBNext Direct™
    Adams, Scott M.
    Patel, Kruti M.
    Emerman, Amy B.
    Bowman, Sarah K.
    Elfe, Charles D.
    Henig, Noa
    Russello, Salvatore
    Barry, Andrew
    Davis, Theodore
    Hendrickson, Cynthia L.
    CANCER RESEARCH, 2017, 77